RedHill Biopharma (RDHL) Commences YELIVA Phase 2 in HCC
Go back to RedHill Biopharma (RDHL) Commences YELIVA Phase 2 in HCC| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.42 -0.01 (2.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $16.54 | |||
| Open | $0.40 | 52 Week Low | $8.10 | |||
| Day High | $0.44 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $0.00 | |||
| Volume | 193,132 | |||||
